Shares rose 7.1% after Vicor reported a sharp revenue increase and forecast further Q4 growth. The outlook calls for 10% sequential product-revenue growth and at least $43 million in royalty revenue, though management noted some Q3 royalty growth was nonrecurring.
Vicor shares dropped 5.9% after the earnings release, reflecting investor disappointment with the cautious outlook and conservative guidance amid expected licensing timing uncertainty and decelerating export proportion.
Vicor Corporation reported mixed third-quarter results, with a significant revenue decline sequentially primarily due to a prior-period patent settlement, yet maintaining strong year-over-year growth.